M&A Deal Summary

Eurazeo PME Acquires I-Tracing

On May 11, 2021, private equity firm Eurazeo PME acquired information technology company I-Tracing from Keensight Capital for 165M EUR

Acquisition Highlights
  • This is Eurazeo PME’s 5th transaction in the Information Technology sector.
  • This is Eurazeo PME’s 10th largest (disclosed) transaction.
  • This is Eurazeo PME’s 40th transaction in France.

M&A Deal Summary

Date 2021-05-11
Target I-Tracing
Sector Information Technology
Buyer(s) Eurazeo PME
Sellers(s) Keensight Capital
Deal Type Secondary Buyout
Deal Value 165M EUR

Target

I-Tracing

Puteaux, France
website
I-Tracing is an independent pure-play provider of cybersecurity services, covering all requirements in this field: cyberdefence (CyberSOC, ICERT, Vulnerability Management Center, offensive audit, 24/7 “follow-the-sun” CyberSOC etc.), consultancy and solution engineering/integration, support and managed services. I-Tracing group comprises the I-Tracing companies based in Puteaux, London, Hong Kong, and Montreal, along with IDENTO I-TRACING Group, which has locations in Asnières and Nantes.

Search 177,612 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

DESCRIPTION

Eurazeo PME, formerly known as OFI Private Equity Capital. Eurazeo PME invests equity and mezzanine capital in secondary buyout transactions of unlisted French companies. The Firm looks for opportunities valued between €50 and €200 million. Areas of interest include chemicals, financial services, consumer services, retail, manufacturing, distribution, and life science. Eurazeo PME was formed in 1997 and is based in Paris.


DEAL STATS #
Overall 58 of 67
Sector (Information Technology) 5 of 7
Type (Secondary Buyout) 24 of 28
Country (France) 40 of 42
Year (2021) 3 of 7
Size (of disclosed) 10 of 16
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-23 Aroma-Zone

Cabrières d Avignon, France

Aroma-Zone is an online retailer that sells its DIY products mainly online but also through a network of seven stores across France. The company is continuously innovating, inspired by constant interaction with its loyal community of customers. Aroma-Zone was formed in 1999 and is based in Cabrières d Avignon, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-12 Trader Interactive

Virginia Beach, Virginia, United States

Trader Interactive is a provider of online marketplaces and digital marketing products serving the lifestyle vehicles and commercial equipment segments. Trader Interactive was founded in 2017 and is based in Virginia Beach, Virginia.

Sell -

Seller(S) 1

DESCRIPTION

Keensight Capital is a private equity investment firm focused on majority and minority growth capital investments in Western European companies. Keensight makes equity investments in a number of situations including the provision of capital to finance growth, either organically or through acquisitions, or the buying out of existing shareholders. The Firm looks to invest €10 to €50 million and will consider business with up to €150 million in revenue. Keensight Capital was formed in 2000 and is based in Paris.


DEAL STATS #
Overall 13 of 16
Sector (Information Technology) 3 of 3
Type (Secondary Buyout) 4 of 6
Country (France) 8 of 9
Year (2021) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-11 Linkbynet

Saint-Denis, France

Linkbynet is a provider of cloud computing and security. Linkbynet was founded in 2000 and is based in Saint-Denis, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-25 Symeres

Groningen, Netherlands

Symeres is a mid-sized European Contract Research Organization for drug discovery and development needs. With over 500 employees at six locations (Groningen, Nijmegen, & Weert in the Netherlands, Prague in the Czech Republic, Oulu in Finland, and Södertälje in Sweden), as well as a business development office in the US, the company offers best-in-class solutions for drug discovery and drug development for small molecules and beyond. Their services span from preclinical hit finding all the way to the delivery of early clinical phase drug substance API. Symeres blends a deep scientific knowledge base with creativity and problem-solving skills to deliver the quality results that clients need.

Buy -